Cleantech Transit, Inc. (CLNO)

Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project could benefit the Company's manufacturing clients worldwide.

The technology used by Phoenix Energy to turn your waste from industry agriculture and forestry into power has many environmental benefits. At Phoenix Energy they are deeply committed to their customers both in reducing their costs of operation and in helping them be good corporate citizens, having a positive impact on the environment. By installing their wood waste gasification systems their customers help to:
o Reduce greenhouse gas emissions.
o Reduce the amount of toxic pollutants in the atmosphere.
o Save landfill space from taking up more of their landscape and Reduce groundwater
Contaminants.
o Improve energy security and reduce dependence on foreign sources of energy.

Energy production from biomass is an effective use of waste products and it also reduces the significant problem of waste disposal. Biomass is a domestic resource that can reduce the amount of coal needed for electricity production. However, biomass has relatively low energy density, so transport and handling costs may make it uneconomical in Australia unless the energy conversion process is close to a concentrated source of biomass, such as a sawmill, sugar mill or pulp mill. There are other problems of odour, disease and controlling wastes when digesters are used.

Cleantech Transit, Inc. (CLNO) is pleased to announce it has met its funding requirement to secure the Company's ability to earn in 25% of the 500KW Merced Project.

The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.

For more information about Cleantech Transit, Inc. visit its website www.cleantechtransitinc.com

**************************************************

Synta Pharmaceuticals Corp. (Nasdaq:SNTA) announced that it will release its second-quarter 2011 financial results before the market opens on Thursday, August 4, 2011. Management will conduct a conference call at 10:00 a.m. (ET) that morning to review the Company's second-quarter financial results. The conference call will be webcast live over the Internet and can be accessed by logging on to the "Investors" section of the Synta Pharmaceuticals website, www.syntapharma.com, prior to the event.

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drug candidates for treating severe medical conditions, including cancer and chronic inflammatory diseases.

**************************************************

National Health Partners, Inc. (NHPR)

National Health Partners, Inc. (NHPR), a leading provider of unique discount healthcare membership programs, announced that it has entered into agreement with a major Hispanic marketing group for the sale of its CARExpress programs. The company also sees growth in new sales of memberships of more than 300% thru the remainder of the year.

Under the new agreement, this national Hispanic marketing group will be promoting the company's CARExpress discount healthcare membership program to Hispanic communities located across the United States, with particular focus on cities and regions containing a large number of Hispanics. With the previously announced plans to increase monthly sales by 75% with its newest and most successful marketing partner, the company now expects sales of new members to grow more than 300% thru the remainder of the year.

More and more people are looking for vision services. By joining the CARExpress program, you will have access to 11,500 vision providers nationwide including: JCPenney, Target, LensCrafters, For Eyes, Sears and thousand of independents. You will be able to save an average of 10% - 50% on most frames, prescription lenses and non-prescription sunglasses. And for those who like to shop by mail, they can use CARExpress mail order program and save an average of 5% - 50% on most contact lenses. Not only do you receive significant savings on eyewear, but Laser Vision Correction (LASIK) is also included in this program. Special discounts on eye examinations at participating locations where approved.

Eye symptoms include vision problems, such as blurred vision, and many other symptoms, such as eye pain, and discharge or bleeding from the eye.
A variety of mild to serious diseases, disorders and conditions can lead to eye symptoms. Eye symptoms, such as blurred vision, can result from minor problems, such as nearsightedness or wearing the wrong eyeglasses. However, eye symptoms can also result from infection, inflammation, trauma, malignancy (cancer), and other abnormal processes.

National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called "CARExpress."CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. The company's primary target customer group is the 47 million Americans who have no health insurance of any kind. The company's secondary target customer group includes the millions of Americans who lack complete health insurance coverage.

Please visit its website at www.nationalhealthpartners.com

**************************************************

Amylin Pharmaceuticals, Inc. (Nasdaq:AMLN), Eli Lilly and Company (NYSE:LLY) and Alkermes, Inc. (Nasdaq:ALKS) announced that the companies have submitted their reply to a complete response letter issued in October 2010 by the U.S. Food and Drug Administration (FDA) regarding BYDUREON™ (exenatide extended-release for injectable suspension), an investigational medication for type 2 diabetes. The companies expect to receive an updated Prescription Drug User Fee Act (PDUFA) action date from the FDA within the next two weeks. Since the reply included additional data, it will likely be categorized as a Class 2 resubmission requiring up to six months for review.

Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drug candidates for the treatment of diabetes, obesity, and other diseases.

**************************************************

Double Eagle Petroleum Co (NasdaqBLE) will report its second quarter 2011 financial and operating results on Thursday, August 4, 2011, by issuing a press release before the market opens and conducting a conference call on that date at 11:00 a.m. Eastern Time. The conference call information is as follows: Dial-In-Number: 1-800-434-1335, Please Request: Double Eagle Second Quarter 2011 Earnings Call, Participant Code: 151845# A recording of the call will be available for delayed playback for one week beginning at approximately 12:00 p.m Eastern Time on August 4, 2011.To access the replay, dial 1-800-704-9804, and provide the confirmation code by entering a "*" then 151845#.

Double Eagle Petroleum Co., an independent energy company, engages in the exploration, development, production, and sale of natural gas and crude oil primarily in the Rocky Mountain Basins of the western United States.

**************************************************************



**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (NHPR.OB).